205.17
Natera Inc (NTRA) 最新ニュース
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Natera awarded 30% ongoing royalty in MRD patent litigation - MSN
M&T Bank Corp Increases Stock Position in Natera, Inc. $NTRA - MarketBeat
What Natera (NTRA)'s New Prospera Transplant Data Momentum Means For Shareholders - simplywall.st
Is It Too Late To Consider Natera (NTRA) After Its Strong Multi Year Share Price Run? - Yahoo Finance
Teacher Retirement System of Texas Has $15.06 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Tells Justices CareDx Made Up Circ. Split In Petition - Law360
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm - TMX Newsfile
Universal Beteiligungs und Servicegesellschaft mbH Has $30.18 Million Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. ($NTRA) CEO and President 2025 Pay Revealed - Quiver Quantitative
[ARS] Natera, Inc. SEC Filing - Stock Titan
Natera (NASDAQ: NTRA) details 2026 meeting agenda, pay votes and equity plan expansion - Stock Titan
Unveiling Natera (NTRA) Q4 outlook: Wall Street estimates for key metrics - MSN
Is It Too Late To Consider Natera (NTRA) After Its Recent Share Price Surge? - simplywall.st
Why (NTRA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Natera (NTRA) Showcases Promising Evidence for Prospera Test at ISHLT Meeting - GuruFocus
17 transplant studies show Prospera flags earlier heart, lung warning signs - Stock Titan
Natera co-founder Sheena Jonathan sells $299,440 in shares By Investing.com - Investing.com India
Natera co-founder Sheena Jonathan sells $299,440 in shares - Investing.com
Natera (NTRA) co-founder’s family trusts sell 1,500 shares under 10b5-1 plan - Stock Titan
Judge hands Natera 30% ongoing royalty in MRD patent battle - MSN
Natera positioned to capture growing $20 billion MRD opportunity: analyst - MSN
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA) - Yahoo Finance
3 Reasons We’re Fans of Natera (NTRA) - Yahoo Finance
Natera, Inc. $NTRA Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Natera, Inc. (NTRA) Stock Analysis: A 23.78% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Natera Sees RS Rating Improve To 76 - Investor's Business Daily
Court orders 30% ongoing royalty for Natera in patent dispute - MSN
KBC Group NV Buys 14,346 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know - Yahoo Finance
Cwm LLC Has $19 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, UFP Technologies, Mettler-Toledo, and Viatris shares are soaring, what you need to know - MSN
Chicago Capital LLC Purchases 12,805 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Natera (NASDAQ:NTRA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Class Action Certification and CLARITY MRD Data Might Change The Case For Investing In Natera (NTRA) - simplywall.st
NTRA Technical Analysis | Trend, Signals & Chart Patterns | NATERA INC (NASDAQ:NTRA) - ChartMill
NTRA Stock Price, Quote & Chart | NATERA INC (NASDAQ:NTRA) - ChartMill
Natera (NTRA) Tops Q4 Earnings and Revenue Estimates - Eastern Progress
Is It Time To Reassess Natera (NTRA) After Its Mixed Share Price Performance? - simplywall.st
Barclays Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $280 - Moomoo
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates - MSN
Natera, Inc. (NASDAQ:NTRA) Short Interest Up 47.2% in March - MarketBeat
NTRA Initiated Coverage On by William Blair -- Rating Outperform - GuruFocus
NATERA INC : WILLIAM BLAIR INITIATES COVERAGE WITH OUTPERFORM RATING - Moomoo
Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst - Benzinga
Natera Inc stock (US6323071042): Is cell-free DNA testing strong enough to unlock sustained growth? - AD HOC NEWS
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma - BioSpace
William Blair initiates Natera stock with Outperform on growth outlook - Investing.com
William Blair initiates Natera stock with Outperform on growth outlook By Investing.com - Investing.com India
大文字化:
|
ボリューム (24 時間):